 | | | | LONDON (Reuters) - AstraZeneca's immunotherapy drug Imfinzi has hit a second important goal by improving overall survival in lung cancer patients, boosting prospects for a medicine that has already got off to a promising commercial launch. | | | | | | MUMBAI (Reuters) - Officials in a third Indian state were checking on Friday if two people had been infected with the brain-damaging Nipah virus that has killed 12 in southern Kerala, although the government described the outbreak as minor. | | | | | | (Reuters) - A California jury on Thursday ordered Johnson & Johnson to pay $4 million in punitive damages to a woman who said she developed cancer after being exposed to asbestos in the company's baby powder, pushing the total damages award in the case to $25.7 million. | | | | | | (Reuters) - U.S. regulators on Thursday approved BioMarin Pharmaceutical Inc's Palynziq for adults with phenylketonuria, a rare metabolic disorder, sending shares of the biotechnology company up 3 percent after hours. | | | | | | WASHINGTON (Reuters) - The U.S. Environmental Protection Agency, under pressure from the chemical industry, has delayed release of a study detailing cancer risks from formaldehyde, according to internal communications seen by Reuters, potentially keeping important health information from the public. | | | | | | GENEVA/KINSHASA (Reuters) - Two dying Ebola patients were spirited out of a Congo hospital by their relatives on motor-bikes, then taken to a prayer meeting with 50 other people, potentially exposing them all to the deadly virus, a senior aid worker said on Thursday. | | | | | | ZURICH (Reuters) - Novartis said its Sandoz division received approval from the European Commission for its biosimilar Zessly (infliximab) in gastroenterological, rheumatological and dermatological diseases. | | | | | | MELBOURNE (Reuters) - An Australian court dismissed an appeal by the nation's anti-trust watchdog in a case against Pfizer Inc in which the regulator alleged the company had used its market power to limit competition for its cholesterol-lowering drug Lipitor. | | | | | | (Reuters) - Shares of Inogen Inc fell nearly 7 percent on Thursday after short seller Citron Research called the oxygen supply device maker the most expensive name in medical technology with no pipeline. | | | | | | (Reuters Health) - People who eat at least two servings a week of oily fish like salmon, mackerel, herring and tuna should keep it up because U.S. doctors still say it's a good way to reduce the risk of heart attacks and strokes. | | | | | |
